Selank: What the Research Actually Shows

← Back to Research Library
Research Library · Cognitive

Selank: What the Research Actually Shows

At a Glance
  • What it is: A synthetic 7-amino-acid peptide developed by Russian researchers, based on a natural fragment called tuftsin.
  • Researchers have studied it for: anxiety and neurasthenia, nootropic (thinking and focus) effects, and how it acts on the GABA calming system.
  • Evidence level: Thin and mostly Russian-language. The human studies are small, and there are no large, independent Western trials confirming them.
  • The short version: Most Selank research is small and published in Russian, and the exact pathway is still an open question. The leading idea points at the brain’s GABA calming system. The human case is not settled, and this is a research summary, not a reason to use anything.

Selank is a synthetic peptide developed by Russian researchers and studied mostly as an anti-anxiety and nootropic (thinking and focus) compound. Most of that research was published in Russian, and the English-language evidence is thin, so this page is honest about how much (and how little) has actually made it into print.

Here is the honest version. Below is what researchers looked at, in what kind of model, and what they observed. We are telling you what researchers found, not what it does for you.

What researchers have studied

Anxiety and neurasthenia trial (Zh Nevrol Psikhiatr Im S S Korsakova, 2008). A study in 62 people with generalized anxiety disorder and neurasthenia (a long-standing “worn out” state). Selank in 30 patients was compared with medazepam, a standard anti-anxiety drug, in 32 patients. Researchers reported the anti-anxiety effect was similar between the two, with Selank also showing anti-fatigue and mild stimulant effects in that group. This is a small study in a Russian-language journal. PMID 18454096. https://pubmed.ncbi.nlm.nih.gov/18454096/

Comparison with phenazepam (Zh Nevrol Psikhiatr Im S S Korsakova, 2014). A later Russian study compared Selank with phenazepam, a benzodiazepine, in people with anxiety disorders. Researchers reported Selank showed anti-anxiety and mild nootropic effects, with better tolerability than the benzodiazepine in that group. Again, a small Russian-language study. PMID 25176261. https://pubmed.ncbi.nlm.nih.gov/25176261/

Selank plus diazepam in rats (Behavioural Neurology, 2017). An animal study, not people. Researchers put rats through chronic mild stress and tested Selank on its own and alongside diazepam using a maze anxiety test. They reported Selank on its own reduced some anxiety measures, and the Selank-plus-diazepam pairing did best against the stress-driven anxiety. Live animal model. PMID 28280289. https://pubmed.ncbi.nlm.nih.gov/28280289/

Gene expression in nerve cells (Frontiers in Pharmacology, 2017). An in vitro study, meaning isolated neuroblastoma cells in a lab dish rather than a live animal. Researchers looked at 84 genes tied to the GABA system (the brain’s main calming signal). Selank alone did not directly change those gene levels, but it shifted how GABA acted on them. The authors said this partly supports the idea that Selank affects how GABA meets its receptor. PMID 28293190. https://pubmed.ncbi.nlm.nih.gov/28293190/

How it works

Selank is a short 7-amino-acid peptide based on a natural body fragment called tuftsin. Russian researchers built it to be more stable than the natural piece.

The leading idea in the research points at the GABA system, the signal that calms brain activity down. In the cell study above, Selank did not switch GABA genes on or off by itself, but it changed how GABA behaved. Other work has pointed at effects on mood-related signals and immune messengers. The honest read: the exact receptor and pathway are still open questions in the published research. No single clean mechanism has been locked down.

What the research does not establish

The honest limits are the whole point here.

  • The evidence base is thin and mostly Russian-language. The human studies are small, and there are no large, independent Western randomized trials confirming them.
  • There is no approved use in the US. Selank is not an FDA-approved drug, and it has not been shown to be effective or safe in the general public.
  • The strongest-sounding findings come from small clinical studies or from animal and cell models. What happened in those settings does not tell you what would happen in a person.
  • Nothing here is a safety conclusion, and this is not a claim that the compound is safe to use.
  • This page is a research summary only. It does not say the compound does anything “for you.”

Anyone telling you the human case is settled is well ahead of the published research.

For Research Use Only. Not for human consumption. Etched Research supplies compounds for laboratory and research use only. Independent identity and purity testing by Janoshik. Nothing on this page is medical advice, a health claim, or a recommendation to use.

Available at Etched Research
Research-grade material, batch COA included. For research use only.
View product →
Scroll to Top